A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
The Pathogenesis and Prognostic Factors of Lymphoma
- Status
- RECRUITING
- Phase
- N/A
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
- Status
- RECRUITING
- Phase
- N/A
Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
- Status
- AVAILABLE
- Phase
- N/A
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
- Status
- COMPLETED
- Phase
- NA
A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Biochemical Role of Circulating microRNAs Expression as Diagnostic Markers for Non-Hodgkin's Lymphoma Patients
- Status
- RECRUITING
- Phase
- N/A
A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China
- Status
- COMPLETED
- Phase
- PHASE1
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel
- Status
- RECRUITING
- Phase
- PHASE1